Literature DB >> 9249616

Cytokine concentration in serum of lupus erythematosus patients: the effect on acute phase response.

J K Lacki1, P Leszczynski, J Kelemen, W Müller, S H Mackiewicz.   

Abstract

In order to get a better insight into cytokine network regulation in systemic lupus erythematosus (SLE), we analyzed levels of interleukin-10 (IL-10), interleukin-6 (IL-6), tumor necrosis factor-alpha (TNF-alpha), and interferon-gamma (IFN-gamma) in the sera from 36 SLE patients. Moreover, C-reactive protein (CRP), alpha-1-acid-glycoprotein (AGP), and alpha-1-antichymotripsin (ACT) serum levels were evaluated. Serum levels of IL-10 and IL-6 were significantly increased when compared with healthy controls. TNF-alpha and IFN-gamma did not differ from normal values. We established the relationship between IL-10 and IL-6 as well as between IL-10 and TNF-alpha. None of the analyzed cytokines correlated with the acute phase protein levels. Based on the obtained data, we conclude that IL-10 may play the superior regulating role in SLE. A lack of correlation between the cytokines and acute phase proteins suggests their independence from cytokine regulation.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9249616

Source DB:  PubMed          Journal:  J Med        ISSN: 0025-7850


  13 in total

1.  Reference distributions for the positive acute phase proteins, alpha1-acid glycoprotein (orosomucoid), alpha1-antitrypsin, and haptoglobin: a comparison of a large cohort to the world's literature.

Authors:  R F Ritchie; G E Palomaki; L M Neveux; O Navolotskaia
Journal:  J Clin Lab Anal       Date:  2000       Impact factor: 2.352

Review 2.  Cytokines and systemic lupus erythematosus.

Authors:  G S Dean; J Tyrrell-Price; E Crawley; D A Isenberg
Journal:  Ann Rheum Dis       Date:  2000-04       Impact factor: 19.103

3.  Increased levels of proinflammatory cytokines and nitric oxide metabolites in neuropsychiatric lupus erythematosus.

Authors:  E Svenungsson; M Andersson; L Brundin; R van Vollenhoven; M Khademi; A Tarkowski; D Greitz; M Dahlström; I Lundberg; L Klareskog; T Olsson
Journal:  Ann Rheum Dis       Date:  2001-04       Impact factor: 19.103

4.  Monoclonal anti-double-stranded DNA autoantibody stimulates the expression and release of IL-1beta, IL-6, IL-8, IL-10 and TNF-alpha from normal human mononuclear cells involving in the lupus pathogenesis.

Authors:  K H Sun; C L Yu; S J Tang; G H Sun
Journal:  Immunology       Date:  2000-03       Impact factor: 7.397

Review 5.  Anticytokine therapies in systemic lupus erythematosus.

Authors:  Antonio La Cava
Journal:  Immunotherapy       Date:  2010-07       Impact factor: 4.196

6.  The analysis of CIS, SOCS1, SOSC2 and SOCS3 transcript levels in peripheral blood mononuclear cells of systemic lupus erythematosus and rheumatoid arthritis patients.

Authors:  Jeng-Ting Tsao; Chia-Chen Kuo; Shih-Chang Lin
Journal:  Clin Exp Med       Date:  2008-09-27       Impact factor: 3.984

7.  Initial validation of a novel protein biomarker panel for active pediatric lupus nephritis.

Authors:  Michiko Suzuki; Kristina Wiers; Elizabeth B Brooks; Kenneth D Greis; Kathleen Haines; Marisa S Klein-Gitelman; Judyann Olson; Karen Onel; Kathleen M O'Neil; Earl D Silverman; Lori Tucker; Jun Ying; Prasad Devarajan; Hermine I Brunner
Journal:  Pediatr Res       Date:  2009-05       Impact factor: 3.756

Review 8.  Cytokine networks in systemic lupus erythematosus.

Authors:  Hooi-Ming Lee; Hidehiko Sugino; Norihiro Nishimoto
Journal:  J Biomed Biotechnol       Date:  2010-04-15

9.  Intercellular adhesion molecules in systemic lupus erythematosus patients with lupus nephritis.

Authors:  Alaa Sabry; Hussein Sheashaa; Amr El-Husseini; Khaled El-Dahshan; Mona Abdel-Rahim; Sherief Refat Elbasyouni
Journal:  Clin Rheumatol       Date:  2007-03-06       Impact factor: 2.980

10.  The effect of long-term glucocorticoids on bone metabolism in systemic lupus erythematosus patients: the prevalence of its anti-inflammatory action upon bone resorption.

Authors:  Izabela Korczowska; Anna Olewicz-Gawlik; Paweł Hrycaj; Jan Lacki
Journal:  Yale J Biol Med       Date:  2003
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.